";s:4:"text";s:6295:" 0000222269 00000 n
0000222430 00000 n
COPEGUS should be given in combination with PEGASYS; it is important to note that COPEGUS should never be given as monotherapy. 0000010569 00000 n
0000004060 00000 n
0000026208 00000 n
0000222858 00000 n
0000224246 00000 n
startxref
h�bb������8�f�;��1�G�c(`� �;
%%EOF
Hydrea 500 mg Hard Capsules. Locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation. 0000029819 00000 n
0000013216 00000 n
0000015272 00000 n
0000010262 00000 n
Excipients with known effect: Contains Lactose Monohydrate 42.2 mg. For the full list of excipients, see section 6.1.
0000011184 00000 n
Copegus is indicated for the treatment of chronic hepatitis C and must only be used as part of a combination regimen with peginterferon alfa-2a or with interferon alfa-2a. 0000009955 00000 n
0000013568 00000 n
<<3D4BB32D03DC894A8F8026A5D28BDBCD>]/Prev 377146/XRefStm 3702>>
0000000016 00000 n
0000021610 00000 n
0000006126 00000 n
0000011625 00000 n
0000009031 00000 n
0000168458 00000 n
0000022900 00000 n
0000223232 00000 n
0000003702 00000 n
0000223446 00000 n
0000222376 00000 n
0000008416 00000 n
He 0000006889 00000 n
0000223500 00000 n
Copegus monotherapy must not be used. The recommended duration of treatment 0000222216 00000 n
0000011492 00000 n
0000009493 00000 n
0000222644 00000 n
Base all dosage on the patient’s actual or ideal weight, whichever is less.
0000222590 00000 n
Name of the medicinal product. 0000223179 00000 n
0000006432 00000 n
0000017754 00000 n
0000016121 00000 n
0000023151 00000 n
0000011031 00000 n
• 1. 0000222751 00000 n
0000007501 00000 n
0000034346 00000 n
0000013837 00000 n
%PDF-1.3 Hydrea is indicated for the treatment of: • 1. stream 0000222323 00000 n
0000009647 00000 n
trailer
0000003890 00000 n
0000224051 00000 n
Chronic Hepatitis C … 0000105514 00000 n
0000007195 00000 n
0000005670 00000 n
0000014480 00000 n
Each capsule contains 500 mg of Hydroxycarbamide. 0000006736 00000 n
0000223125 00000 n
0000015547 00000 n
See PEGASYS Package Insert for all instructions regarding PEGASYS dosing and administration. 0000222697 00000 n
2.1 Chronic Hepatitis C Monoinfection Adult Patients The recommended dose of COPEGUS tablets is provided in Table 1. 0000223607 00000 n
0000223714 00000 n
HYDREA is used alone or in conjunction with other antitumor agents or radiation therapy to treat neoplastic diseases. %PDF-1.4
%����
0000012260 00000 n
0000034957 00000 n
x���7���)�e#�"�c�XE��7�$��;-i���؞��e�ҎuKj��}&bs�� 0000222537 00000 n
Individualize treatment based on tumor type, disease state, response to treatment, patient risk factors, and current clinical practice standards. 0000223393 00000 n
K@�0�c���^�Y��m�[ ��--�?j)D�����՟�Y�����wH��o���ٝU�1��{g�^���Ox.�p���1���;0��}Y]=��O�rg�5%�{����_ַ�'{G��o����I�hY����r�����_@��W�N/! 0000245128 00000 n
0000067548 00000 n
0000224300 00000 n
0000034662 00000 n
0000011338 00000 n
0000008569 00000 n
0000003037 00000 n
0000014729 00000 n
Qualitative and quantitative composition.
4j\���������آ'�D&�RZ�����Biip6D��AI�Ȅ�`����\�@�A�UR
��i�"
x�
P�2��s@� ����K30�2F0�0Ԣ�: ���z,�I��bJ`�ĸ�-�OL��X~0)���Nb���x�a*#�&q��X��$��b9/8��@��A��?��c���R�/�.>f�ʐ������ad`�`cc@��0 k��3������ׁ�&�)�4��t ������<4>����gp��R�-Ձ��Gٍ��WZy��������W�0턥��9����I/H[X͚'|�]�/s����u@#w1��� �` ���|
0000022338 00000 n
0000067495 00000 n
720 0 obj
<>stream
0000222911 00000 n
COPEGUS should be taken with food. 0000006279 00000 n
Please refer to the package insert of interferon alfa 2a or peginterferon alfa 2a products for additional information.
0000010109 00000 n
0000168405 00000 n
0000019207 00000 n
endstream
endobj
719 0 obj
<>/Filter/FlateDecode/Index[187 400]/Length 36/Size 587/Type/XRef/W[1 1 1]>>stream
0000034904 00000 n
COPEGUS should be given in combination with PEGASYS; it is important to note that COPEGUS should never be given as monotherapy. 0000028561 00000 n
0000223767 00000 n
endstream
endobj
588 0 obj
< 0000144797 00000 n
0000010415 00000 n
0000005822 00000 n
0000223944 00000 n
0000009339 00000 n